Eisai Co., Ltd. (TYO:4523)
Japan · Delayed Price · Currency is JPY 4,583.00
+67.00 (1.48%)
Dec 18, 2025, 3:30 PM JST
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
73.68M JPY
Profits / Employee
4.52M JPY
Market Cap
1.29T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10,917 | -150 | -1.36% |
| Mar 31, 2024 | 11,067 | -9 | -0.08% |
| Mar 31, 2023 | 11,076 | -246 | -2.17% |
| Mar 31, 2022 | 11,322 | 85 | 0.76% |
| Mar 31, 2021 | 11,237 | 239 | 2.17% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Olympus | 29,297 |
| Daiichi Sankyo Company | 19,765 |
| M3, Inc. | 15,360 |
| Astellas Pharma | 13,643 |
| Kyowa Kirin | 5,669 |
Eisai News
- 2 days ago - China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms? - South China Morning Post
- 9 days ago - Eisai Co., Ltd. (ESAIY) Discusses Value Creation Initiatives, ESG, and Dementia Area Contributions Transcript - Seeking Alpha
- 9 days ago - Eisai Co., Ltd. (ESAIY) Discusses Value Creation Initiatives, ESG, and Dementia Area Contributions - Slideshow - Seeking Alpha
- 14 days ago - Eisai And Biogen Report Long-Term Benefits Of LEQEMBI In Early Alzheimer's Disease - Nasdaq
- 15 days ago - Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 - PRNewsWire
- 16 days ago - Eisai : Etalanetug Demonstrates Reduction Of EMTBR-tau243 In Phase Ib/II Alzheimer's Study - Nasdaq
- 16 days ago - Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025 - PRNewsWire
- 20 days ago - Biogen, Eisai File In Japan To Make Leqembi A Weekly At-Home Alzheimer's Shot - Benzinga